Copy For Citation
Gulec C., Coban N., Ozsait-Selcuk B. Ş., Sirma-Ekmekci S., Yildirim O., Erginel-Unaltuna N.
Experimental cell research, vol.353, pp.6-15, 2017 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
353
-
Publication Date:
2017
-
Doi Number:
10.1016/j.yexcr.2017.02.028
-
Journal Name:
Experimental cell research
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.6-15
-
Keywords:
Nuclear receptors, Target genes, ChIP-on-chip, Atherosclerosis, ORPHAN RECEPTOR-ALPHA, GLAND HORMONE MELATONIN, LIGAND-BINDING DOMAIN, NUCLEAR RECEPTOR, HEME OXYGENASE-1, TRANSCRIPTIONAL ACTIVATION, ENDOTHELIAL-CELLS, CANCER-CELLS, REV-ERB, IL-6 PRODUCTION
-
Istanbul University Affiliated:
Yes
Abstract
ROR-alpha is a nuclear receptor, activity of which can be modulated by natural or synthetic ligands. Due to its possible involvement in, and potential therapeutic target for atherosclerosis, we aimed to identify ROR-alpha target genes in monocytic and endothelial cell lines.